Karim discusses secondary findings from the ELITE trial of timing for estradiol initiation, which reveal a notable impact on Aβ biomarkers of Alzheimer disease.
Roksana Karim, MD, PhD
Advertisement
Articles by Roksana Karim, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Patient Care Online
1
Investigational Oral Agent ALZ-801 Slows Brain Atrophy and Cognitive Decline in APOE4 Homozygotes with Early AD
2
Why Do Women Suffer in Silence with Genitourinary Syndrome of Menopause?
3
Mazdutide Demonstrates Superior Glycemic Control and Weight Loss vs Semaglutide in Head-to-Head Trial
4
MHT and Alzheimer Risk: New Evidence for a Critical Window, with Roksana Karim, MD, PhD
5
